Regulus Therapeutics
RGLS
#9090
Rank
A$0.15 B
Marketcap
$2.29
Share price
5.11%
Change (1 day)
-47.08%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of December 2024 : A$0.12 Billion

According to Regulus Therapeutics's latest financial reports the company has A$0.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.12 B249.23%
2023-12-31A$34.88 M-39.38%
2022-12-31A$57.54 M-30.91%
2021-12-31A$83.28 M106.01%
2020-12-31A$40.42 M-17.04%
2019-12-31A$48.73 M146.37%
2018-12-31A$19.78 M-74.29%
2017-12-31A$76.94 M-27.12%
2016-12-31A$0.10 B-32.56%
2015-12-31A$0.15 B-19.78%
2014-12-31A$0.19 B52.72%
2013-12-31A$0.12 B35.39%
2012-12-31A$94.39 M153.76%
2011-12-31A$37.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$7.41 B 6,050.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$13.12 B 10,785.84%๐Ÿ‡ซ๐Ÿ‡ท France
A$3.77 B 3,034.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$8.99 B 7,361.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$4.28 B 3,455.83%๐Ÿ‡บ๐Ÿ‡ธ USA
A$66.67 M-44.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.27 B 14,230.21%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA